For type 2 diabetes, almost any Part D plan covers at least one GLP-1, though specific formulary choices vary by plan
The American Diabetes Association upgraded GLP-1 agonists to preferred second-line agents for patients with cardiovascular comorbidities in its 2024 Standards of Care, elevating the drug class above sulfonylureas and DPP-4 inhibitors for many clinical scenarios
Its important to note that Mounjaro may not be suitable for everyone, and a thorough assessment by a healthcare professional is necessary to determine if it is the right choice
Katie observed: Justice Lewis extensive judicial experience, deep understanding of the law, and lifelong dedication to serving the people of our state make him an outstanding choice for the federal bench
At moderate doses (8 mg weekly), GI issues increased but were offset by significantly improved weight loss results
The impact of Hanseniaspora vineae fermentation and ageing on lees on the terpenic aromatic profile of white wines of the Albillo variety